Keith Gottesdiener

Statistics

Publications

114

Citations

11.2K

H-Index

Active since

1978

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Columbia University

Jazz Pharmaceuticals (United States)

Cornell University

Keith Gottesdiener is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and clinical pharmacology.

ORCID

Publications per year

1978–2021

114

Publications

114

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Susan Buchbinder, Devan V. Mehrotra, Ann Duerr et al. · The Lancet · 2008 · 1.7K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPARγ Agonists: A Potential Mechanism of Insulin Sensitization

Terry P. Combs, John A. Wagner, Joel P. Berger et al. · Endocrinology · 2002 · 568 citations

Medicine, Endocrinology, Pharmacology +17

Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

Gary Herman, Arthur Bergman, Catherine Stevens et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 499 citations

Medicine, Endocrinology, Pharmacology +17

Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist

Peter Kühnen, Karine Clément, Susanna Wiegand et al. · New England Journal of Medicine · 2016 · 470 citations

Medicine, Endocrinology, Pharmacology +17

[ <sup>18</sup> F]MK-9470, a positron emission tomography (PET) tracer for <i>in vivo</i> human PET brain imaging of the cannabinoid-1 receptor

H. Donald Burns, Koen Van Laere, Sandra Sanabria Bohórquez et al. · Proceedings of the National Academy of Sciences · 2007 · 315 citations · Full text

Medicine, Neuroscience, Pharmacology +9

1–5 of 114